Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01456949 · ClinicalTrials.gov registry record · NA
Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)
A NA study of Paroxysmal Atrial Fibrillation (PAF), sponsored by Medtronic Cardiac Ablation Solutions.
- Completed
- Registry status
- NA
- Development phase
- 402
- Enrollment target
- 20
- Study locations
NCT01456949 is a NA study of Paroxysmal Atrial Fibrillation (PAF) that has completed, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 402 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT01456949, a NA study of Paroxysmal Atrial Fibrillation (PAF), has completed, sponsored by Medtronic Cardiac Ablation Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 402 participants
- Enrollment target
- 20
- Study locations
Study Summary
The Post-Approval Study (PAS) is a prospective multi-center, non-randomized, single arm, controlled,unblinded clinical study designed to provide long-term safety and effectiveness of the Arctic Front® Cardiac CryoAblation System.
Conditions Studied
Interventions
- DEVICE Medtronic Arctic Front® Cardiac CryoAblation System
Study Locations (20)
Florida
- Daytona Heart Group - Daytona Beach
- Broward General Medical Center - Fort Lauderdale
- University of Florida - Gainesville
Minnesota
- Metropolitan Cardiology Consultants PA - Coon Rapids
- St. Mary's Hospital - Mayo Clinic - Rochester
- HealthEast St. Joseph's Hospital - Saint Paul
Georgia
- Emory University Hospital - Atlanta
- WellStar Kennestone Hospital - Marietta
Massachusetts
- Massachusetts General Hospital - Boston
- Brigham and Women's Hospital - Boston
Alaska
- Alaska Heart Institute - Anchorage
Arizona
- Banner Good Samaritan Medical Center - Phoenix
California
- Good Samaritan Hospital - San Jose
Colorado
- Colorado Heart and Vascular - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 402 participants |
| Start Date | 2012-06-26 |
| Est. Completion | 2017-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01456949
The ClinicalTrials.gov registry entry for NCT01456949 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 402 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Ablation Solutions, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Paroxysmal Atrial Fibrillation (PAF) appearing as the primary indexed condition, and to 1 intervention - of which Medtronic Arctic Front® Cardiac CryoAblation System is the first listed.
NCT01456949 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Florida, Minnesota, Georgia.
Frequently Asked Questions
What is clinical trial NCT01456949 about?
NCT01456949 is a clinical study titled "Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)". The Post-Approval Study (PAS) is a prospective multi-center, non-randomized, single arm, controlled,unblinded clinical study designed to provide long-term safety and effectiveness of the Arctic Front® Cardiac CryoAblation System.
What is the current status of trial NCT01456949?
This trial is currently completed. It is a NA study. The enrollment target is 402 participants. The study started on 2012-06-26. Estimated completion is 2017-11-30.
What conditions does trial NCT01456949 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation (PAF).
What interventions are being tested in trial NCT01456949?
The interventions under investigation include: Medtronic Arctic Front® Cardiac CryoAblation System (DEVICE).
Who is sponsoring clinical trial NCT01456949?
This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01456949 being conducted?
This trial has 20 study locations across Alaska, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation (PAF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation
COMPLETED · NA
-
Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.